7
Ar), 8.72 (br, 1H, N-H). 13C NMR (CDCl3) δ: 90.8, 120.2, 123.3,
129.5, 130.0, 132.2, 137.1, 139.8, 169.1.
3. Lippmann, W. US 4,267,189, 1981.
ACCEPTED MANUSCRIPT
4. Hardcastle, I. R.; Liu, J. F.; Valeur, E.; Watson, A.; Ahmed, S. U.;
Blackburn, T. J.; Bennaceur, K.; Clegg, W.; Drummond, C.;
Endicott, J. A.; Golding, B. T.; Griffin, R. J.; Gruber, J.; Haggerty,
K.; Harrington, R. W.; Hutton, C.; Kemp, S.; Lu, X. C.;
McDonnell, J. M.; Newell, D. R.; Noble, M. E. M.; Payne, S. L.;
Revill, C. H.; Riedinger, C.; Xu, Q.; Lunec, J. J. Med. Chem.
2011, 54, 1233-1243.
5. Wrobel, J.; Dietrich, A.; Woolson, S. A.; Millen, J.; McCaleb, M.;
Harrison, M. C.; Hohman, T. C.; Sredy, J.; Sullivan, D. J. Med.
Chem. 1992, 35, 4613-4627.
6. De Clercq, E., J. Med. Chem. 1995, 38, 2491-2517.
7. Volpe, R.; Mautner, L. S., Appl. Ther. 1961, 3, 521-528.
8. Bernstein, P. R.; Aharony, D.; Albert, J. S.; Andisik, D.; Barthlow,
H. G.; Bialecki, R.; Davenport, T.; Dedinas, R. F.; Dembofsky, B.
T.; Koether, G.; Kosmider, B. J.; Kirkland, K.; Ohnmacht, C. J.;
Potts, W.; Rumsey, W. L.; Shen, L. H.; Shenvi, A.; Sherwood, S.;
Stollman, D.; Russell, K. Bioorg. Med. Chem. Lett. 2001, 11,
2769-2773.
4.21. Reaction of lithium dibutyl phosphonate with N-
sulfinylimine 1.
To the solution of dibutyl phosphonate (99 mg, 0.722 mmol)
in diethyl ether (2 mL) was added dropwise n-butyllithium
solution in hexane (2.5M, 0.28 mL, 0.70 mmol) at 0 oC. After 15
min a solution of (S)-N-sulfinylimine 1 (62 mg, 0.23 mmol) in
diethyl ether (3 mL) was added. The reaction mixture was stirred
o
at 0 C for 2 hrs and quenched with sat. NH4Cl solution. The
resulting mixture was then extracted with CH2Cl2 (3 × 5 mL).
The combined organic layers were dried over MgSO4, filtered,
and evaporated. The obtained crystals of phthalimide 7 were
washed with ether- hexane 1:1 (v/v) mixture. Yield 9 mg (16%).
The spectroscopic data matched those reported in the literature:44
1H NMR (400 MHz, CDCl3) δ: 7.74-7.79 (m, 2H, Ar), 7.85-7.92
(m, 2H, Ar).
9. Zhuang, Z. P.; Kung, M. P.; Mu, M.; Kung, H. F. J. Med. Chem.
1998, 41, 157-166.
10. Kulkarni, S. K.; Ninan, I. Fundam. Clin. Pharmacol. 2000, 14,
529-539.
The washings were evaporated and purified using column
chromatography on silica gel AcOEt:Hexane 1:2.3 (v.v) to give
O,O-dibutyl-S-t-butyl phosphorothioate 8 (oil) 55 mg (90%). IR
11. (a) Chen, M. D.; Zhou, X.; He, M. Z.; Ruan, Y. P.; Huang, P. Q.
Tetrahedron 2004, 60, 1651-1657; (b) Deniau, E.; Couture, A.;
Grandclaudon, P. Tetrahedron: Asymmetry 2008, 19, 2735-2740.
12. Li, T. T.; Zhou, S. B.; Wang, J.; Acena, J. L.; Soloshonok, V. A.;
Liu, H. Chem. Commun. 2015, 51, 1624-1626.
1
(ATR): 1251, 1020, 976, 610 cm-1. H NMR (400 MHz, CDCl3)
δ: 0.92 (t, J = 7.3 Hz, 6H), 1.34-1.45 (m, 4H), 1.53 (d, J = 1.3 Hz,
9H), 1.62-1.70 (m, 4H), 3.98-4.14 (m, 4H). 13C NMR (CDCl3) δ:
13.6, 18.7, 32.2 (J = 7.1 Hz), 32.7 (J = 6.4 Hz), 49.8 (J = 4.5 Hz),
67.0 (J = 7.1 Hz). 31P NMR (CDCl3) δ: 25.3. HRMS (ESI) m/z
calcd for C12H28O3PS (M+H)+ 283.1491, found: 283.1488.
13. Lamblin, M.; Couture, A.; Deniau, E.; Grandclaudon, P.
Tetrahedron: Asymmetry 2008, 19, 111-123.
14. Comins, D. L.; Schilling, S.; Zhang, Y. C. Org. Lett. 2005, 7, 95-
98.
15. Fujioka, M.; Morimoto, T.; Tsumagari, T.; Tanimoto, H.;
Nishiyama, Y.; Kakiuchi, K. J. Org. Chem. 2012, 77, 2911-2923.
16. Suzuki, Y.; Kanai, M.; Matsunaga, S., Chem. Eur. J. 2012, 18,
7654-7657.
4.22. Dibutyl 2,3-dihydro-1H-isoindolin-1-one-3-phosphonate
(9).
17. Bisai, V.; Unhale, R. A.; Suneja, A.; Dhanasekaran, S.; Singh, V.
K. Org. Lett. 2015, 17, 2102-2105.
To a solution of (S)-N-sulfinylimine 1 (50 mg, 0.187 mmol)
and dibutyl phosphonate (77 mg, 0.562 mmol) in dry
dichloromethane (3 mL) was added K2CO3 (130 mg, 0.935
mmol). The reaction mixture was stirred for 24 h. Precipitate was
centrifuged and the solution was evaporated. The residue was
dissolved in ethanolic 4M HCl solution (0.1 mL) and the mixture
was left for 24 h. The solution was made alkaline with sat.
NaHCO3 solution and extracted with dichloromethane (3 x 5
mL). Organic extracts were dried with MgSO4, filtered and
evaporated. Product was purified using column chromatography
on silica gel AcOEt:Hexane 3:1 v/v). 42 mg (70%) of white
18. Sallio, R.; Lebrun, S.; Schifano-Faux, N.; Goossens, J. F.;
Agbossou-Niedercorn, F.; Deniau, E.; Michon, C. Synlett 2013,
24, 1785-1790.
19. Di Mola, A.; Palombi, L.; Massa, A. An overview on asymmetric
synthesis of 3-substituted indolinones. In Targets in Heterocyclic
Systems: Chemistry and Properties; Attanasi, O. A.; Noto, R.;
Spinelli, D., Eds.; Italian Society of Chemistry: Rome, 2014; 18,
113-140.
20. (a) Ellman, J. A.; Owens, T. D.; Tang, T. P. Acc. Chem. Res. 2002,
35, 984-995. (b) Robak, M. T.; Herbage, M. A.; Ellman, J. A.
Chem. Rev. 2010, 110, 3600-3740.
21. Sun, X. W.; Liu, M.; Xu, M. H.; Lin, G. Q. Org. Lett. 2008, 10,
1259-1262.
1
crystals. IR (ATR): 3219, 1694, 1657, 991 cm-1. H NMR (400
22. Fernandez-Salas, J. A.; Rodriguez-Fernandez, M. M.; Maestro, M.
C.; Garcia-Ruano, J. L. Eur. J. Org. Chem. 2014, 5265-5272.
23. Huang, Z.; Zhang, M.; Wang, Y.; Qin, Y. Synlett 2005, 1334-
1336.
24. Cainelli, G.; Giacomini, D.; Galletti, P., Eur. J. Org. Chem. 1999,
61-65.
MHz, CDCl3) δ: 0.80 (t, J = 7.4 Hz, 3H, CH3), 0.89 (t, J = 7.4 Hz,
3H, CH3), 1.13-1.43 (m, 6H, CH2x3), 1.55-1.64 (m, 2H, CH2),
3.64-3.73 (m, 1H, O-CH), 3.86-3.95 (m, 1H, O-CH), 4.02-4.15
(m, 2H, O-CH2), 4.95 (d, J = 13.6 Hz, 1H, C3-H), 6.62 (br, 1H,
N-H), 7.54 (t, J = 7.4 Hz, 1H, Ar), 7.62 (td, J = 1.2 Hz, 7.4 Hz,
1H, Ar), 7.73-7.77 (m, 1H, Ar), 7.89 (dd, J = 0.8 Hz, 7.4 Hz, 1H,
Ar). 13C NMR (CDCl3) δ: 13.4 (J = 7.1 Hz), 18.5 (J = 13.5 Hz),
32.2 and 32.4 (J = 5.6 Hz), 54.1 (J = 156.0 Hz), 67.0 and 67.5 (J
= 7.1 Hz), 124.0 (J = 1.1 Hz), 124.1 (J = 2.6 Hz), 128.8 (J = 2.2
Hz), 131.7 (J = 4.9 Hz), 132.1 (J = 2.6 Hz), 140.1 (J = 6.4 Hz),
170.7 (J = 3.0 Hz). 31P NMR (CDCl3) δ: 14.0. HRMS (ESI) m/z
calcd for C16H25NO4P (M+H)+ 326.1516, found: 326.1515.
25. Cogan, D. A.; Liu, G.; Ellman, J., Tetrahedron, 1999, 55, 8883-
8904.
26. Davis, F. A.; McCoull, W., J. Org. Chem. 1999, 64, 3396-3397.
27. (a) Fernández, I.; Khiar, N., Chem. Rev. 2003, 103, 3651-3706, (b)
Pellissier, H. Tetrahedron, 2006, 62, 5559-5601.
28. Cotter, F. E. Patent: WO2010/125343 A1, 2010.
29. Cogan, D. A.; Liu, G. C.; Kim, K. J.; Backes, B. J.; Ellman, J. A.
J. Am. Chem. Soc., 1998, 120, 8011-8019.
30. Chen, M. W.; Chen, Q. A.; Duan, Y.; Ye, Z. S.; Zhou, Y. G.
Chem. Comm, 2012, 1698-1700.
31. Deniau, E.; Enders, D., Tetrahedron, 2001, 57, 2581-2588.
32. Deniau, E.; Enders, D.; Couture A.; Grandclaudon P.,
Tetrahedron: Asymmetry 2003, 14, 2253-2258.
33. Zhou, J. Q.; Sheng, W. J.; Jia, J. H.; Ye, Q.; Gao, J. R.; Jia, Y. X.
Tetrahedron Lett., 2013, 54, 3082-3084.
Acknowledgments
This work was supported by the National Science Centre in
Poland Grant no. 2013/09/B/ST5/03664.
34. Evans, D. A.; Faul, M. M.; Colombo, L.; Bisaha, J. J.; Clardy, J.;
Cherry, D., J. Am. Chem. Soc, 1992, 114, 5977-5985.
35. Chelouan, A.; Recio, R.; Alcudia, A.; Khiar, N.; Fernandez, I.,
Eur. J. Org. Chem., 2014, 6935-6944.
References
1. Atack, J. R. Expert Opin. Invest. Drugs 2005, 14, 601-618.
2. Shirasaka, T.; Kunitake, T.; Tsuneyoshi, I. Brain Res. 2009, 1300,
105-113.
36. Syed, M. K.; Casey; M. Eur. J. Org. Chem. 2011, 7207-7214.